Inhibition of reverse transcriptase activity by 2′,3′-dideoxythymidine 5′-triphosphate and its derivatives modified on the 3′ position

This publication has 14 references indexed in Scilit:

• Initial studies on the cellular pharmacology of 2′,3′-dideoxycytidine, an inhibitor of HTLV-III infectivity
  Biochemical Pharmacology, 1986
• ADMINISTRATION OF 3'-AZIDO-3'-DEOXYTHYMIDINE, AN INHIBITOR OF HTLV-III/LAV REPLICATION, TO PATIENTS WITH AIDS OR AIDS-RELATED COMPLEX
  The Lancet, 1986
• EFFECTS OF SURAMIN ON HTLV-III/LAV INFECTION PRESENTING AS KAPOSI'S SARCOMA OR AIDS-RELATED COMPLEX: CLINICAL PHARMACOLOGY AND SUPPRESSION OF VIRUS REPLICATION IN VIVO
  The Lancet, 1985
• ANTIMONIOTUNGSTATE (HPA 23) TREATMENT OF THREE PATIENTS WITH AIDS AND ONE WITH PRODROME
  The Lancet, 1985
• Effects of 2′,3′‐dideoxynucleosides on mammalian cells and viruses
  Journal of Cellular Physiology, 1984
• Suramin Protection of T Cells in Vitro Against Infectivity and Cytopathic Effect of HTLV-III
  Science, 1984
• Synthetic nucleosides and nucleotides. XXI. On the synthesis and biological evaluations of 2'-deoxy-.ALPHA.-D-ribofuranosyl nucleosides and nucleotides.
  Chemical and Pharmaceutical Bulletin, 1984
• Suramin: A potent inhibitor of the reverse transcriptase of RNA tumor viruses
  Cancer Letters, 1979
• Inhibition of RNA-dependent DNA polymerase of murine oncornaviruses by ammonium-5-tungsto-2-antimoniate
  Biochemical and Biophysical Research Communications, 1975
• Nucleosides. V. The Monomesylates of 1-(2'-Deoxy-β-D-lyxofuranosyl)thymine^1,2
  The Journal of Organic Chemistry, 1964